CA1265742A1 - Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy - Google Patents

Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy

Info

Publication number
CA1265742A1
CA1265742A1 CA000497664A CA497664A CA1265742A1 CA 1265742 A1 CA1265742 A1 CA 1265742A1 CA 000497664 A CA000497664 A CA 000497664A CA 497664 A CA497664 A CA 497664A CA 1265742 A1 CA1265742 A1 CA 1265742A1
Authority
CA
Canada
Prior art keywords
process according
stimulation factor
reagent
buffer
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA000497664A
Other languages
English (en)
French (fr)
Other versions
CA1275041C (show.php
Inventor
Otto-Henning Wilhelms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to CA000606692A priority Critical patent/CA1275041A/en
Publication of CA1265742A1 publication Critical patent/CA1265742A1/en
Application granted granted Critical
Publication of CA1275041C publication Critical patent/CA1275041C/xx
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
CA000497664A 1984-12-21 1985-12-13 Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy Granted CA1265742A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000606692A CA1275041A (en) 1984-12-21 1989-07-26 Device for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3446714.9 1984-12-21
DE19843446714 DE3446714A1 (de) 1984-12-21 1984-12-21 Verfahren zum nachweis des vorliegens einer allergie und zum spezifischen nachweis des fuer die allergie verantwortlichen allergens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000606692A Division CA1275041A (en) 1984-12-21 1989-07-26 Device for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy

Publications (2)

Publication Number Publication Date
CA1265742A1 true CA1265742A1 (en) 1990-02-13
CA1275041C CA1275041C (show.php) 1990-10-09

Family

ID=6253433

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000497664A Granted CA1265742A1 (en) 1984-12-21 1985-12-13 Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy

Country Status (8)

Country Link
US (1) US5116731A (show.php)
EP (1) EP0185335B1 (show.php)
JP (1) JPH0630633B2 (show.php)
AT (1) ATE62936T1 (show.php)
AU (1) AU596087B2 (show.php)
CA (1) CA1265742A1 (show.php)
DE (2) DE3446714A1 (show.php)
ES (1) ES8705635A1 (show.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803109D0 (en) * 1988-02-11 1988-03-09 Deltanine Research Ltd Improvements in/relating to clinical testing monitoring & pharmaceutical compositions for treatment of auto-immune diseases
GB2246627B (en) * 1990-08-01 1994-11-30 Patricia Mary Becket Robertson Allergy test kit and apparatus
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
AU2917992A (en) * 1991-12-05 1993-06-28 Board Of Regents Of The University Of Nebraska, The Allergen specific immunoglobulin-e producer test for diagnosing allergies
DE19781554D2 (de) * 1997-01-20 2000-07-13 Orpegen Pharma Gmbh Basophilen-Degranulationstest
AU2003902792A0 (en) * 2003-06-03 2003-06-19 Advanced Diagnostic Systems Pty Ltd A method for early detection of allergic sensitisation
US9023641B2 (en) * 2004-05-13 2015-05-05 Advanced Animal Diagnostics Microfluidic device and leucocyte antigen mediated microfluidic assay
EP1913393A4 (en) * 2005-06-16 2010-03-03 Univ California PARALLEL ALLERGIESTEST IMMUNA BASEBALL AND DEVICE FOR FLUORESCENT EXCITING WITH EVANESCENCE FIELD
JP2007174950A (ja) * 2005-12-27 2007-07-12 National Cardiovascular Center 抗炎症薬および／または抗アレルギー薬の同定方法
US20080011058A1 (en) * 2006-03-20 2008-01-17 The Regents Of The University Of California Piezoresistive cantilever based nanoflow and viscosity sensor for microchannels
EP2005155B1 (en) * 2006-03-24 2021-06-30 Advanced Animal Diagnostics, Inc. Mastitis assay employing a microfluidic chamber assembly
US8191403B2 (en) * 2007-03-27 2012-06-05 Richmond Chemical Corporation Petroleum viscosity measurement and communication system and method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527932C2 (de) * 1974-07-02 1983-04-21 Pentapharm AG, 4052 Basel Säureadditionssalze von Tripeptidderivaten und deren Verwendung als Substrate zur Bestimmung von Plasmakallikrein
SE407058B (sv) * 1974-12-05 1979-03-12 Kabi Ab Nya kromogena enzymsubstrat for serinproteaser
US4162941A (en) * 1974-12-05 1979-07-31 Ab Kabi Method for determining a proteolytic enzyme
DE2854987A1 (de) * 1978-12-20 1980-06-26 Boehringer Mannheim Gmbh Diagnostische mittel zum nachweis proteolytischer enzyme und dafuer geeignete chromogene
GB2045431B (en) * 1979-02-26 1983-04-20 Technicon Instr Immunoassay utilising two particulate reagents
DE2936543A1 (de) * 1979-09-10 1981-04-09 Behringwerke Ag, 3550 Marburg Chromogene verbindungen
DE3017721A1 (de) * 1980-05-09 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Mittel zum nachweis esterolytischer und/oder proteolytischer enzyme und dafuer geeignete substrate
DE3147763A1 (de) * 1981-12-02 1983-06-09 Stickl, Helmut, Prof.Dr.Med., 8033 Krailling Nachweisverfahren zur in vitro-bestimmung des bei einer allergie korrespondierenden allergens
DE3211254A1 (de) * 1982-03-26 1983-09-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zum nachweis des vorliegens einer allergie und zum spezifischen nachweis des fuer die allergie verantwortlichen allergens
US4487155A (en) * 1982-08-03 1984-12-11 Puritan-Bennett Corporation Pneumatically powered oxygen pressure loss alarm system
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
DE3404821A1 (de) * 1984-02-10 1985-08-14 Werner & Mertz Gmbh, 6500 Mainz Verfahren zum nachweis von allergenhaltigem hausstaub

Also Published As

Publication number Publication date
US5116731A (en) 1992-05-26
AU596087B2 (en) 1990-04-26
ATE62936T1 (de) 1991-05-15
ES8705635A1 (es) 1987-05-16
EP0185335B1 (de) 1991-04-24
EP0185335A3 (en) 1987-08-05
AU5126685A (en) 1986-06-26
DE3446714A1 (de) 1986-06-26
JPS61155861A (ja) 1986-07-15
JPH0630633B2 (ja) 1994-04-27
EP0185335A2 (de) 1986-06-25
DE3582661D1 (de) 1991-05-29
CA1275041C (show.php) 1990-10-09
ES550284A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
Cuatrecasas Perturbation of the insulin receptor of isolated fat cells with proteolytic enzymes: Direct measurement of insulin-receptor interactions
McCaman et al. Fluorimetric method for the determination of phenylalanine in serum
IMANARI et al. URINARY, SALIVARY, AND PLASMA
CA1265742A1 (en) Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy
Gerasimova et al. Fluorometric method for phenylalanine microplate assay adapted for phenylketonuria screening.
CN105334211B (zh) 一种同时检测尿液中钠和肌酐的试剂盒
US4039388A (en) Diagnostic test for Niemann-Pick disease
JPS588840B2 (ja) プロトロンビンの測定方法
US4458015A (en) Reagent for the optical determination of the blood coagulation
AU625355B2 (en) Reagent for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy
Wiesner et al. A new assay for proteases using fluorescent labeling of proteins
ABELLA et al. A method for simultaneous determination of plasma and erythrocyte antioxidant status. Evaluation of the antioxidant activity of vitamin E in healthy volunteers
Evans et al. Prevalence of alpha 1-antitrypsin Pi types among newborn infants of different ethnic backgrounds
CA1275041A (en) Device for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy
JPS58178258A (ja) アレルギ−の存在の検出及びアレルギ−を誘導するアレルゲンの特異的検出の方法並びに白血球プロテア−ゼ
Lorentz Evaluation of α-amylase assays with 4-nitrophenyl-α-oligosaccharides as substrates
EP0440775B1 (en) Factor ix chromogenic assay
US4335203A (en) Method for identifying potential contrast media reactors
Heeley et al. Cystic fibrosis--its biochemical detection.
CA1070227A (en) Measurement of alkaline phosphatase levels in body fluids
CN114460295A (zh) 一种全血检测胸苷激酶1的试剂盒及检测方法
Seal et al. Comparison of Commercially Available Radial Immunodiffusion Kits for the Determination of Serum α 1-Antitrypsin Concentrations
Forman et al. Neonatal screening for biotinidase deficiency
HART et al. Quantitative in vitro response of thyroid tissue to thyrotropic hormone
EP1173764B1 (en) Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12

Legal Events

Date Code Title Description
MKLA Lapsed